GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Stock Based Compensation

InMode (InMode) Stock Based Compensation

: $23.6 Mil (TTM As of Dec. 2023)
View and export this data going back to 2019. Start your Free Trial

InMode's Stock Based Compensation for the three months ended in Dec. 2023 was $6.3 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was $23.6 Mil.


InMode Stock Based Compensation Historical Data

The historical data trend for InMode's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Premium Member Only Premium Member Only 1.56 12.85 11.96 24.45 23.60

InMode Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.15 4.21 6.51 6.56 6.32

InMode Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.6 Mil.


InMode Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of InMode's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


InMode (InMode) Business Description

Traded in Other Exchanges
Address
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.